Importance of viral genomic composition in modulating glycoprotein content on the surface of influenza virus particles

Virology

Volumn 414, Issue 1, 2011, Pages 51-62

  Moulès, Vincent ^a   Terrier, Olivier ^a,b   Yver, Matthieu ^a   Riteau, Beatrice ^a,c   Moriscot, Christine ^d,e   Ferraris, Olivier ^a   Julien, Thomas ^a   Giudice, Emmanuel ^f   Rolland, Jean Paul ^f   Erny, Alexandra ^a   Bouscambert Duchamp, Maude ^a,g   Frobert, Emilie ^a,g   Rosa Calatrava, Manuel ^a   Pu Lin, Yi ^h   Hay, Alan ^h   Thomas, Daniel ^f   Schoehn, Guy ^d,e   Lina, Bruno ^a,g  

^a UNIVERSITÉ LYON 1   (France)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c CEMAGREF   (France)

^d INSTITUT DE BIOLOGIE STRUCTURALE   (France)

^e EUROPEAN MOLECULAR BIOLOGY LABORATORY   (France)

^f UNIVERSITÉ DE RENNES 1   (France)

^g HOSPICES CIVILS DE LYON   (France)

^h NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

Cryo electron microscopy (cryo EM); Haemagglutinin (HA); Influenza; Neuraminidase (NA); Orthomyxoviridae; Viral glycoprotein

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ; RNA POLYMERASE; VIRUS GLYCOPROTEIN; VIRUS SIALIDASE;

ANIMAL CELL; ARTICLE; CELL STRAIN; CONTROLLED STUDY; CRYOELECTRON MICROSCOPY; ENZYME ACTIVITY; GENOME ANALYSIS; INFLUENZA VIRUS; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; STRAIN DIFFERENCE; VIROGENESIS; VIRUS EXAMINATION; VIRUS GENE; VIRUS GENOME; VIRUS MORPHOLOGY; VIRUS PARTICLE; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS SHAPE; VIRUS SIZE; VIRUS VIRULENCE;

ANIMALS; CELL LINE; CRYOELECTRON MICROSCOPY; DOGS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; NEURAMINIDASE; RNA REPLICASE; VIRAL PROTEINS; VIRION;

ORTHOMYXOVIRIDAE;

EID: 79955537438     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.03.011     Document Type: Article

References (42)

1. Baez M., Palese P., Kilbourne E.D. Gene composition of high-yielding influenza vaccine strains obtained by recombination. J. Infect. Dis. 1980, 141(3):362-365. Mar.
2. Barman S., Nayak D.P. Lipid raft disruption by cholesterol depletion enhances influenza A virus budding from MDCK cells. J. Virol. 2007, 81(22):12169-12178. Nov.
3. Booy F.P., Ruigrok R.W., van Bruggen E.F. Electron microscopy of influenza virus. A comparison of negatively stained and ice-embedded particles. J. Mol. Biol. 1985, 184(4):667-676. Aug 20.
4. Calder L.J., Wasilewski S., Berriman J.A., Rosenthal P.B. Structural organization of a filamentous influenza A virus. Proc. Natl Acad. Sci. U.S.A. 2010, 107(23):10685-10690. Jun 8.
5. Choppin P.W., Murphy J.S., Tamm I. Studies of two kinds of virus particles which comprise influenza A2 virus strains. III. Morphological characteristics: independence to morphological and functional traits. J. Exp. Med. 1960, 112:945-952. Nov 1.
6. Eichelberger M.C., Hassantoufighi A., Wu M., Li M. Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay. Virol. J. 2008, 5:109. Sep 26.
7. Ferraris O., Kessler N., Lina B. Sensitivity of influenza viruses to zanamivir and oseltamivir: a study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice. Antivir. Res. 2005, 68(1):43-48. Oct.
8. Fujiyoshi Y., Kume N.P., Sakata K., Sato S.B. Fine structure of influenza A virus observed by electron cryo-microscopy. EMBO J. 1994, 13(2):318-326. Jan 15.
9. Gong J., Xu W., Zhang J. Structure and functions of influenza virus neuraminidase. Curr. Med. Chem. 2007, 14(1):113-122.
10. Gubareva L.V., Bethell R., Hart G.J., Murti K.G., Penn C.R., et al. Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en. J. Virol. 1996, 70(3):1818-1827. Mar.
11. Harris A., Cardone G., Winkler D.C., Heymann J.B., Brecher M., et al. Influenza virus pleiomorphy characterized by cryoelectron tomography. Proc. Natl Acad. Sci. U.S.A. 2006, 103(50):19123-19127. Dec 12.
12. Hausmann J., Kretzschmar E., Garten W., Klenk H.D. Biosynthesis, intracellular transport and enzymatic activity of an avian influenza A virus neuraminidase: role of unpaired cysteines and individual oligosaccharides. J. Gen. Virol. 1997, 78(Pt 12):3233-3245. Dec.
13. Hayase Y., Uno F., Nii S. Ultrahigh-resolution scanning electron microscopy of MDCK cells infected with influenza viruses. J. Electron. Microsc. (Tokyo.) 1995, 44(5):281-288. Oct.
14. Hoffmann E., Neumann G., Kawaoka Y., Hobom G., Webster R.G. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl Acad. Sci. U.S.A. 2000, 97(11):6108-6113. May 23.
15. Huiskonen J.T., Overby A.K., Weber F., Grünewald K. Electron cryo-microscopy and single-particle averaging of Rift Valley fever virus: evidence for GN-GC glycoprotein heterodimers. J. Virol. 2009, 83(8):3762-3769. Apr.
16. Inglis S.C., Carroll A.R., Lamb R.A., Mahy B.W. Polypeptides specified by the influenza virus genome I. Evidence for eight distinct gene products specified by fowl plague virus. Virology 1976, 74(2):489-503. Oct 15.
17. Kawaoka Y., Krauss S., Webster R.G. Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J. Virol. 1989, 63(11):4603-4608. Nov.
18. Kundu A., Avalos R.T., Sanderson C.M., Nayak D.P. Transmembrane domain of influenza virus neuraminidase, a type II protein, possesses an apical sorting signal in polarized MDCK cells. J. Virol. 1996, 70(9):6508-6515. Sep.
19. Lamb R.A., Krug R.M. Fields Virology 2001, 1:1487-1579. Lippincott Williams and Wilkins, New York. D.M. Knipe, P.M. Howley (Eds.).
20. Li C., Hatta M., Nidom C.A., Muramoto Y., Watanabe S., et al. Reassortment between avian H5N1 and human H3N2 influenza viruses creates hybrid viruses with substantial virulence. Proc. Natl Acad. Sci. U.S.A. 2010, 107(10):4687-4692. Mar 9.
21. Loney C., Mottet-Osman G., Roux L., Bhella D. Paramyxovirus ultrastructure and genome packaging: cryo-electron tomography of sendai virus. J. Virol. 2009, 83(16):8191-8197. Aug.
22. Matrosovich M., Matrosovich T., Carr J., Roberts N.A., Klenk H.D. Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors. J. Virol. 2003, 77(15):8418-8425. Aug.
23. McKimm-Breschkin J.L., McDonald M., Blick T.J., Colman P.M. Mutation in the influenza virus neuraminidase gene resulting in decreased sensitivity to the neuraminidase inhibitor 4-guanidino-Neu5Ac2en leads to instability of the enzyme. Virology 1996, 225(1):240-242. Nov 1.
24. Moules V., Ferraris O., Terrier O., Giudice E., Yver M., et al. In vitro characterization of naturally occurring influenza H3NA- viruses lacking the NA gene segment: toward a new mechanism of viral resistance?. Virology 2010, 404(2):215-224. Sep 1.
25. Nayak D.P., Reichl U. Neuraminidase activity assays for monitoring MDCK cell culture derived influenza virus. J. Virol. Meth. 2004, 122(1):9-15. Dec 1.
26. Nayak D.P., Balogun R.A., Yamada H., Zhou Z.H., Barman S. Influenza virus morphogenesis and budding. Virus Res. 2009, 143(2):147-161. Aug.
27. Neumann G., Noda T., Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 2009, 459(7249):931-939. Jun 18.
28. Noda T., Sagara H., Yen A., Takada A., Kida H., et al. Architecture of ribonucleoprotein complexes in influenza A virus particles. Nature 2006, 439(7075):490-492. Jan 26.
29. Palese P., Shaw M.L. Orthomyxoviridae: the viruses and their replication. Fields Virology 2007, 1647-1689. Lippincott Williams and Wilkins, Philadelphia. 5th edition. D.M. Knipe, P.M. Howley, D.E. Griffi, R.A. Lamb, M.A. Martin, B. Roizman, S.E. Strauss (Eds.).
30. Roberts P.C., Compans R.W. Host cell dependence of viral morphology. Proc. Natl Acad. Sci. U.S.A. 1998, 95(10):5746-5751. May 12.
31. Ruigrok R.W., Andree P.J., Hooft van Huysduynen R.A., Mellema J.E. Characterization of three highly purified influenza virus strains by electron microscopy. J. Gen. Virol. 1984, 65(Pt 4):799-802. Apr.
32. Ruigrok R.W., Hewat E.A., Wade R.H. Low pH deforms the influenza virus envelope. J. Gen. Virol. 1992, 73(Pt 4):995-998. Apr.
33. Scheiffele P., Roth M.G., Simons K. Interaction of influenza virus haemagglutinin with sphingolipid-cholesterol membrane domains via its transmembrane domain. EMBO J. 1997, 16(18):5501-5508. Sep 15.
34. Sherman M.B., Freiberg A.N., Holbrook M.R., Watowich S.J. Single-particle cryo-electron microscopy of Rift Valley fever virus. Virology 2009, 387(1):11-15. Apr 25.
35. Simpson-Holley M., Ellis D., Fisher D., Elton D., McCauley J., et al. A functional link between the actin cytoskeleton and lipid rafts during budding of filamentous influenza virions. Virology 2002, 301(2):212-225. Sep 30.
36. Skehel J.J., Wiley D.C. Influenza haemagglutinin. Vaccine 2002, 20(Suppl 2):S51-S54. May 15.
37. Staschke K.A., Colacino J.M., Baxter A.J., Air G.M., Bansal A., et al. Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en. Virology 1995, 214(2):642-646. Dec 20.
38. Terrier O., Rolland J.P., Rosa-Calatrava M., Lina B., Thomas D., et al. Parainfluenza virus type 5 (PIV-5) morphology revealed by cryo-electron microscopy. Virus Res. 2009, 142(1-2):200-203. Jun.
39. Tumpey T.M., Basler C.F., Aguilar P.V., Zeng H., Solorzano A., et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 2005, 310(5745):77-80. Oct 7.
40. Wanitchang A., Kramyu J., Jongkaewwattana A. Enhancement of reverse genetics-derived swine-origin H1N1 influenza virus seed vaccine growth by inclusion of indigenous polymerase PB1 protein. Virus Res. 2010, 147(1):145-148. Jan.
41. Yamaguchi M., Danev R., Nishiyama K., Sugawara K., Nagayama K. Zernike phase contrast electron microscopy of ice-embedded influenza A virus. J. Struct. Biol. 2008, 162(2):271-276. May.
42. Zhang J., Pekosz A., Lamb R.A. Influenza virus assembly and lipid raft microdomains: a role for the cytoplasmic tails of the spike glycoproteins. J. Virol. 2000, 74(10):4634-4644. May.